Buy or sell Biofourmis stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Biofourmis Stock

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.

Founded

2015

Notable Investors

SoftBank Vision Fund

Headquarters

Boston MA, US

Total Funding

$144M

About Biofourmis Stock

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.

Investors

SoftBank Vision Fund

One97, WeWork, OYO, goPuff, Grab, DoorDash, View, Rappi, Nuro, Flexport

Funding History

December 2015$100K
August 2016$1.0M
May 2017$500K
December 2017$5.0M
May 2018$2.0M
May 2019$35.0M
September 2020$100M

Management

Founder & CEO

Kuldeep Singh Rajput

CO-Founder & MD

Wendou Niu

Chief Product Officer

Sylvain Goblet

CTO

Milan Shah

COO

Jaydev Thakkar

Board Member

Anvesh Ramineni

VP, Data Science

Nandakumar Selvaraj

VP Of Software Development

Siddalingamurthy BG

Board Observer

Ryan Collins

VP, Human Resources

Andy Zucker

Chief Technology Officer

Milan Shah

Board member and Medical Advisor

Maulik Majmudar

VP Operations

Trace Brookins

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Biofourmis or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo